In markets with a lot of provider consolidation, employers are looking at innovative ways to deliver care to their employees for less money, such as on-site clinics or telehealth, explained Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform. VIDE
In markets with a lot of provider consolidation, employers are looking at innovative ways to deliver care to their employees for less money, such as on-site clinics or telehealth, explained Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform.
Transcript
How are employers responding to increased provider consolidation?
The provider landscape has been changing rapidly over the last 5, 10, even 15 years. There’s been an incredible amount of consolidation where providers come together, whether its hospital to hospital, or its healthcare systems acquiring physician groups, which is what we’re seeing now.
While its often done under the auspices of economies of scale and improving care coordination and continuity by bringing providers together, unfortunately, we don’t see any evidence that quality gets better. But, we do see mounds of evidence that prices go up as a result, so employers are very concerned about this and are starting to increasingly use benefit designs and provider network designs that will help shift their population members toward providers that offer better value overall. However, that can be very tricky to do in markets where there’s a dominant provider who puts the kibosh on doing that sort of approach.
So, it’s going to be increasingly challenging in the markets where providers are highly concentrated for employers to do innovative things like that. They are looking at on-site clinics, near-site clinics, and retail clinics expanding telehealth. All of these alternatives are less expensive sites of care, but eventually, there might be a need for government to intervene if the prices just keeping going up in the way that they are and really make healthcare unaffordable.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More